Sickle Cell Anaemia Testing Market Size, Share, Growth, Forecast and Outlook (2024-2031)

Global Sickle Cell Anemia Testing Market is Segmented By Test Type (Hemoglobin S Solubility Test and Sodium Metabisulfite Test, Hemoglobinopathy (Hb) Evaluation, Genetic Testing (DNA analysis), DNA Sequencing, Others), By Product Type (Kits, Reagents, By End-User (Hospitals, Diagnostic Centers, Others), and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031

Sickle Cell Anemia Testing Market Overview

Global Sickle Cell Anemia Testing Market reached US$ YY million in 2023 and is expected to reach US$ YY million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.

To diagnose sickle cell disease, a sickle cell test looks for aberrant hemoglobin in the blood. Sickle cell anemia is characterized by the presence of these crescent or sickle-shaped red blood cells (RBCs), which are easily distinguishable from regular round RBCs.

The most common types of tests used to find sickle cell anemia include Hemoglobin S Solubility Test and Sodium Metabisulfite Test, Hemoglobinopathy (Hb) Evaluation, Genetic Testing (DNA analysis), DNA Sequencing and others.

Sickle Cell Anemia Testing Market Scope

For more details on this report – Request for Sample

Sickle Cell Anemia Testing Market Dynamics: Drivers & Restraints

Increasing prevalence of sickle cell anemia disease worldwide 

The increase in the prevalence of sickle cell anemia cases is expected to drive the market growth. Sickle cell tests evaluate the existence and relative quantity of hemoglobin S in a blood sample or discover abnormalities in the genes that make hemoglobin to assist in diagnosing sickle cell anemia and/or identify persons with the sickle cell characteristic.

For instance, according to the report by the CDC, sickle cell disease affects almost 100,000 Americans. 1 out of 365 African-Americans born with sickle cell disease each year. SCD occurs among about 1 out of every 16,300 Hispanic-American births. About 1 in 13 Black or African-American babies is born with sickle cell trait (SCT).

Each year about 300,000 infants are born with major haemoglobin disorders including more than 2,00,000 cases of sickle-cell anemia in Africa. Thus, the increasing prevalence of the disease condition is expected to drive the market growth.

Restraint

High cost of the advanced testing   

Next-generation sequencing (NGS) and DNA microarrays are examples of advanced testing techniques that are very accurate and insightful, but they are also very expensive. This may put people and healthcare organizations at a financial disadvantage, especially in environments with limited resources. Thus, high cost acts as a hindering factor of the market growth.

Sickle Cell Anemia Testing Market Segment Analysis

The global sickle cell anaemia testing market is segmented based on strip type, diabetes type, end-user, and region.

Kits segment accounted for 54.2% of the market share 

Sickle cell anemia kits are designed for point-of-care testing, they can be used conveniently in clinics, hospitals, or even at home. No complex laboratory equipment is necessary, making them ideal for resource-limited settings or situations where quick results are needed.

The majority of kits yield results in a matter of minutes, facilitating prompt diagnosis and prompt beginning of treatment or referral for additional assessment. This can potentially avoid issues and speed up care. The increase in the launch of advanced kits that gives the results rapidly are expected to drive the segment growth.

For instance, in June 2023, Mylab Discovery Solutions introduced a novel, strip-based test named PathoCatch Sickle Cell Rapid Test for diagnosing Sickle Cell Anemia swiftly and accurately.

Sickle Cell Anemia Testing Market Geographical Analysis

North America is expected to hold a significant position in the global sickle cell anaemia testing market share

North America is expected to hold the dominant position in the market growth due to the increasing prevalence of the disease condition and the advancements in the products that are launched. The strong government support in research and developmental activities of the test solutions and kits is expected to drive market growth in the region.

The majority of US and Canadian states have screening programs in place to guarantee early detection. Testing is easier to get and more convenient due to new quick and point-of-care tests. Research, testing, and treatment program funding encourage market expansion. Thus, the above factors are expected to hold the market growth in the forecast period.

COVID-19 Impact Analysis

COVID-19 has impacted the market growth significantly. The onset of the lockdown and has disrupted the supply chain analysis and the diagnosis and testing of the disease conditions have been reduced due to the unavailability of the test kits and also the diagnostic centers and the hospitals have been shut down for non-essential disease conditions.

Competitive Landscape

The leading companies with a significant market share B. Braun Medical Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Terumo Europe NV, Becton and Dickinson Company, Zenroxmed Healthcare, Shenzhen Hawk Medical Instrument Co., Ltd (Hawkmed), Baxter, ICU Medical Inc., Micrel Medical Devices SA, and QuadMed, Inc among others.

Why Purchase the Report?

• To visualize the global sickle cell anemia testing market segmentation based on test type, product type, end-user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development. 
• Excel data sheet with numerous data points of sickle cell anemia testing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global sickle cell anemia testing market report would provide approximately 61 tables, 59 figures, and 180 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies